Canaccord Genuity Reiterates Buy Rating on CVRx Inc (CVRX)

Go back to Canaccord Genuity Reiterates Buy Rating on CVRx Inc (CVRX)

Cantor Fitzgerald Reiterates Overweight Rating on CVRx Inc (CVRX)

October 23, 2024 6:19 AM EDT

Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating and $14.00 price target on CVRx Inc (NASDAQ: CVRX).

The analyst comments "Investment Summary. We reiterate our Overweight rating and 12-month price target of $14 on CVRx (CVRX) following our survey of heart failure specialists, cardiologists, and... More